Popular Trials
Corticosteroid
Vision Training for Cortical Blindness
Recruiting1 award4 criteria
Rochester, New York
This trial aims to create a new way of visual training for people with normal vision and those who have vision problems due to stroke. The training method is based on statistical learning theories to make the training easier
Behavioural Intervention
Recruitment Methods for Stroke Rehabilitation
Recruiting1 award4 criteria
Toronto, Ontario
This trial focuses on understanding the impact of stroke in Canada and how research studies can help improve rehabilitation treatments. It mentions that certain groups, like women and people with aphasia, are often excluded from stroke
Popular Filters
Phase 3 Trials
Nonsteroidal Anti-Inflammatory Drug
Indomethacin for Premature Birth
Recruiting1 awardPhase 3
Toronto, Ontario
"This trial aims to study the use of a single low-dose of a medicine called indomethacin in preventing severe brain bleeding in babies born very early. Currently, the standard treatment involves three doses
Checkpoint Inhibitor
Nivolumab + Relatlimab vs Pembrolizumab with Chemotherapy for Lung Cancer
Recruiting2 awardsPhase 3
Rochester, New York
This trial aims to compare how well two different drug combinations (Nivolumab and Relatlimab with chemotherapy versus Pembrolizumab with chemotherapy) work in treating participants with advanced or recurrent
Trials With No Placebo
Psoriatic arthritis for Psoriatic Arthritis
Recruiting1 award5 criteria
Toronto, Ontario
The goal of this clinical trial is to test the concurrent validity of the Clarius handheld ultrasound devices versus gold-standard device to detect characteristic features of healthy and rheumatic joints in adults Psoriatic Arthtritis patients (i.e. anatomical structures and vascular flow).
Behavioural Intervention
Family Physician Consultations for Rheumatoid Arthritis
Recruiting1 award1 criteria
Waterloo, Ontario
This trial aims to see if adding a family doctor to a team of rheumatologists can help improve the overall health of people with rheumatoid arthritis. The family doctor will focus on vaccinations, heart
Recreational water users for Gastroenteritis
Recruiting1 award3 criteria
Port Perry, Ontario
Swimming and other recreational water activities at public beaches are increasingly popular leisure activities among Canadians. However, harmful algal blooms caused by blue-green algae (i.e., cyanobacteria) have also been increasing reported at Canadian public beaches in recent years. These algal blooms can cause various acute illnesses among recreational water users through ingestion, inhalation of aerosols, or skin contact with contaminated water. In addition, blue-green algae blooms and their toxins can cause illnesses in pets and wildlife. Currently, baseline data are lacking on the risk of recreational water illness from exposure to blue-green algae blooms in Canada. This study will identify the burden of recreational water illness among recreational water users at four targeted beach sites in Ontario, Manitoba and Nova Scotia, over a two-year period. A prospective cohort study design will be used. We will determine the risk of acquiring acute illness outcomes in recreational water users, as well as their pet dogs, that engage in different levels of water contact at beaches at risk of blue-green algae blooms. We will examine differences in illness risks by gender, age, and location. We will examine relationships between cyanobacterial cell counts, toxin levels, and environmental conditions with the risk of acute illness among participants. Overall, results will provide important data on the risk of recreational water illness from exposure to blue-green algae and their toxins in Canadian beach settings.
Cannabidiol
New CBD Capsule vs Epidyolex for Healthy Adults
Recruiting1 awardPhase 1
Guelph, Ontario
"This trial is looking at how a new capsule form of CBD compares to the already approved Epidyolex in terms of how the body processes it. The study will give participants both products in different conditions
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.